Free Trial
→ Musk Warns. Trump Acts. Your Retirement May Depend on It (From American Alternative) (Ad)tc pixel Free IOVA Stock Alerts

Iovance Biotherapeutics (IOVA) SEC Filings & 10K Form

Iovance Biotherapeutics logo
$2.14 -0.07 (-3.08%)
As of 01:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Iovance Biotherapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/29/2025
3:06 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2025
4:15 PM		Iovance Biotherapeutics (Filer)
Form 424B5
08/22/2025
4:18 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2025
12:46 PM		Iovance Biotherapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
07/17/2025
7:12 PM		BlackRock, Inc. (Filed by)
Iovance Biotherapeutics (Subject)
Form SCHEDULE 13G/A
07/15/2025
6:36 AM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
4:15 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
4:15 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2025
3:46 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:47 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:49 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:50 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:51 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
4:15 PM		Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2025
4:00 PM		Iovance Biotherapeutics (Filer)
Form ARS
04/28/2025
4:00 PM		Iovance Biotherapeutics (Filer)
Form DEF 14A
04/28/2025
4:05 PM		Iovance Biotherapeutics (Filer)
Form DEFA14A
03/18/2025
7:30 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:05 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:05 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:32 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:32 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:33 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:30 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:31 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:15 PM		Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/12/2025
4:17 PM		Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:22 AM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2025
4:59 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
5:00 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
5:01 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
4:15 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
4:16 PM		Iovance Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/02/2024
4:25 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/21/2024
4:15 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:50 PM		Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
11/12/2024
6:11 PM		Iovance Biotherapeutics (Subject)
Maynard Ryan D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
8:03 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
4:15 PM		Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
7:38 AM		Iovance Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/16/2024
5:30 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
5:32 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
5:33 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:52 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:53 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:54 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:56 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:IOVA) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners
This Massive Market is Ripe for Disruption by this Nasdaq
Fanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...
i2i Marketing Group, LLC | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel
2013 Bitcoin miner reveals his trading system (free)
While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...
Crypto Swap Profits | Sponsoredtc pixel
“Shadow Group” in Washington, DC Could Crash Market
New Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...
Altimetry | Sponsoredtc pixel
Did you spot this in the Oval Office last week?
When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...
InvestorPlace | Sponsoredtc pixel
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...
Stansberry Research | Sponsoredtc pixel